Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Schmidt

Showing results (121-130 of 196) with videos related to

Pageof 20
Sort By:
Pharmacotherapy|January 14, 2019
Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization StudyKasper Bruun Kristensen, Øystein Karlstad, Jaana E Martikainen, et al.
Clinical Epidemiology|July 29, 2021
Nordic Health Registry-Based Research: A Review of Health Care Systems and Key RegistriesKristina Laugesen, Jonas F Ludvigsson, Morten Schmidt, et al.
Neurology|November 8, 2014
Preadmission use of nonaspirin nonsteroidal anti-inflammatory drugs and 30-day stroke mortalityMorten Schmidt, Erzsébet Hováth-Puhó, Christian Fynbo Christiansen, et al.
BMJ Open|November 19, 2017
Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort studySarah-Jo Sinnott, Kathryn E Mansfield, Morten Schmidt, et al.
Journal of the American College of Cardiology|October 2, 2024
Risk of Ischemic Stroke After Patent Foramen Ovale ClosureKasper Bonnesen, Kasper Korsholm, Asger Andersen, et al.
BMJ (Clinical Research Ed.)|March 11, 2017
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort studyMorten Schmidt, Kathryn E Mansfield, Krishnan Bhaskaran, et al.
BMJ Open|January 11, 2017
Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort studyMorten Schmidt, Kathryn E Mansfield, Krishnan Bhaskaran, et al.
International Journal of Cardiology|May 6, 2017
Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort studyJens Sundbøll, Erzsébet Hováth-Puhó, Kasper Adelborg, et al.
International Journal of Cardiology|February 15, 2020
The interaction effect of cardiac and non-cardiac comorbidity on myocardial infarction mortality: A nationwide cohort studyMorten Schmidt, Erzsébet Horváth-Puhó, Anne Gulbech Ording, et al.
Thrombosis Research|February 21, 2022
Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolismKasper Bonnesen, Uffe Heide-Jørgensen, Lisbeth Wellejus Albertsen, et al.
Pageof 20

Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
Pharmacotherapy|January 14, 2019
Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization StudyKasper Bruun Kristensen, Øystein Karlstad, Jaana E Martikainen, et al.
Clinical Epidemiology|July 29, 2021
Nordic Health Registry-Based Research: A Review of Health Care Systems and Key RegistriesKristina Laugesen, Jonas F Ludvigsson, Morten Schmidt, et al.
Neurology|November 8, 2014
Preadmission use of nonaspirin nonsteroidal anti-inflammatory drugs and 30-day stroke mortalityMorten Schmidt, Erzsébet Hováth-Puhó, Christian Fynbo Christiansen, et al.
BMJ Open|November 19, 2017
Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort studySarah-Jo Sinnott, Kathryn E Mansfield, Morten Schmidt, et al.
Journal of the American College of Cardiology|October 2, 2024
Risk of Ischemic Stroke After Patent Foramen Ovale ClosureKasper Bonnesen, Kasper Korsholm, Asger Andersen, et al.
BMJ (Clinical Research Ed.)|March 11, 2017
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort studyMorten Schmidt, Kathryn E Mansfield, Krishnan Bhaskaran, et al.
BMJ Open|January 11, 2017
Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort studyMorten Schmidt, Kathryn E Mansfield, Krishnan Bhaskaran, et al.
International Journal of Cardiology|May 6, 2017
Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort studyJens Sundbøll, Erzsébet Hováth-Puhó, Kasper Adelborg, et al.
International Journal of Cardiology|February 15, 2020
The interaction effect of cardiac and non-cardiac comorbidity on myocardial infarction mortality: A nationwide cohort studyMorten Schmidt, Erzsébet Horváth-Puhó, Anne Gulbech Ording, et al.
Thrombosis Research|February 21, 2022
Validation of the Danish Comorbidity Index for Acute Myocardial Infarction for predicting one-year mortality in patients with venous thromboembolismKasper Bonnesen, Uffe Heide-Jørgensen, Lisbeth Wellejus Albertsen, et al.
Pageof 20